| Jerry Lee Scott, | |
|
411 Sunset St, Elkhart, KS 67950-5001 | |
| (620) 697-2131 | |
| (620) 697-4643 |
| Full Name | Jerry Lee Scott |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 411 Sunset St, Elkhart, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528522075 | NPI | - | NPPES |
| 1-09441 | Other | KS | KANSAS PHARMACY LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-09441 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jerry Lee Scott, Po Box 637, Elkhart, KS 67950-0637 Ph: (620) 697-2131 | Jerry Lee Scott, 411 Sunset St, Elkhart, KS 67950-5001 Ph: (620) 697-2131 |
News Archive
Infants born to women who have diets high in calories and fat during pregnancy have an increased risk of developing liver disease, which can lead to obesity and diabetes later in life, Kevin Grove, a researcher at Oregon Health and Science University and the Developmental Obesity Research Consortium, said on Friday at the 10th International Congress on Obesity in Sydney.
Recipients of kidney paired donation through a national program, also called kidney exchange, experience equivalent outcomes when compared with all other living donor kidney transplant recipients, according to a recent analysis.
Blue Belt Technologies, Inc., a medical device company focused on developing the next generation of "smart" surgical instruments providing precise robotic control for use initially in orthopedic procedures and then for other surgical specialties including neurosurgery, spinal and otolaryngology, announced today that it has received CE Mark for the Navio™ PFS System.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the expansion of the lorcaserin marketing and supply agreement between Arena Pharmaceuticals, Inc.'s wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Eisai Inc. Lorcaserin is an investigational drug candidate intended for weight management.
SRI International and the Stanford University School of Medicine announced today that they have established the MISTRAL (Multidisciplinary Initiative for Surgical Technology Research Advanced Laboratory) Collaborative, a program to accelerate the innovation of medical devices and bring them to market faster.
› Verified 7 days ago